Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly
AssigneeRevealix, Inc.
InventorsAdrianna Cantu, Gary Johnson
Life of this patent
Estimating the term…
Loading patent…
AssigneeRevealix, Inc.
InventorsAdrianna Cantu, Gary Johnson
Estimating the term…
The present invention relates to systems and methods for early detection, assessment, monitoring and prevention of pathophysiological conditions originating and/or emanating from skin or localized tissues, including but not limited to acute or chronic episodes of soft tissue pathology, wound, injury, dermatological or rheumatoid condition where bio-signal patterns, biomarkers or other identifiable elements or references would deviate from baseline. Specifically, the present invention relates to methods and systems specially designed and adapted for early detection of a latent pathogenic bio-signal anomaly using multiple aggregated sensors before the anomaly would otherwise be detectable.
A scanner for detecting a latent pathogenic skin condition in a patient comprising:
A monitoring system for detecting a latent pathogenic skin condition in a patient comprising:
A method for detecting a latent pathogenic skin condition in a patient comprising:
Dependencies are inferred from the claim text.